Literature DB >> 18838142

Retention mechanisms in micellar liquid chromatography.

M J Ruiz-Angel1, S Carda-Broch, J R Torres-Lapasió, M C García-Alvarez-Coque.   

Abstract

Micellar liquid chromatography (MLC) is a reversed-phase liquid chromatographic (RPLC) mode with mobile phases containing a surfactant (ionic or non-ionic) above its critical micellar concentration (CMC). In these conditions, the stationary phase is modified with an approximately constant amount of surfactant monomers, and the solubilising capability of the mobile phase is altered by the presence of micelles, giving rise to diverse interactions (hydrophobic, ionic and steric) with major implications in retention and selectivity. From its beginnings in 1980, the technique has evolved up to becoming a real alternative in some instances (and a complement in others) to classical RPLC with hydro-organic mixtures, owing to its peculiar features and unique advantages. This review is aimed to describe the retention mechanisms (i.e. solute interactions with both stationary and mobile phases) in an MLC system, revealed in diverse reports where the retention behaviour of solutes of different nature (ionic or neutral exhibiting a wide range of polarities) has been studied in a variety of conditions (with ionic and non-ionic surfactants, added salt and organic solvent, and varying pH). The theory is supported by several mechanistic models that describe satisfactorily the retention behaviour, and allow the measurement of the strength of solute-stationary phase and solute-micelle interactions. Suppression of silanol activity, steric effects in the packing pores, anti-binding behaviour, retention of ionisable compounds, compensating effect on polarity differences among solutes, and the contribution of the solvation parameter model to elucidate the interactions in MLC, are commented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18838142     DOI: 10.1016/j.chroma.2008.09.053

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  7 in total

1.  Determination of six drugs used for treatment of common cold by micellar liquid chromatography.

Authors:  Adel Ehab Ibrahim; Ayman Abo Elmaaty; Heba Mohamed El-Sayed
Journal:  Anal Bioanal Chem       Date:  2021-06-17       Impact factor: 4.142

2.  Studying the suitability of hybrid micelle liquid chromatography for estimating the lipophilicity of some partial dopamine agonists used to attain the reward circuit.

Authors:  M E K Wahba; D El Wasseef; D El Sherbiny
Journal:  R Soc Open Sci       Date:  2021-05-26       Impact factor: 2.963

3.  Incorporating physiologically relevant mobile phases in micellar liquid chromatography for the prediction of human intestinal absorption.

Authors:  Dina S Shokry; Laura J Waters; Gareth M B Parkes; John C Mitchell
Journal:  Biomed Chromatogr       Date:  2018-08-16       Impact factor: 1.902

4.  Comparison of Phenolic Compound Separations by HPTLC and PPEC with SDS as the Mobile Phase Component.

Authors:  Beata Polak; Adam Traczuk; Marta Kamińska; Małgorzata Kozyra
Journal:  J Anal Methods Chem       Date:  2019-01-10       Impact factor: 2.193

5.  Predicting Pharmacokinetic Properties of Potential Anticancer Agents via Their Chromatographic Behavior on Different Reversed Phase Materials.

Authors:  Małgorzata Janicka; Anna Mycka; Małgorzata Sztanke; Krzysztof Sztanke
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

6.  Application of Micellar Mobile Phase for Quantification of Sulfonamides in Medicated Feeds by HPLC-DAD.

Authors:  Ewelina Patyra; Krzysztof Kwiatek
Journal:  Molecules       Date:  2021-06-22       Impact factor: 4.411

7.  Development of a New Radiofluorinated Quinoline Analog for PET Imaging of Phosphodiesterase 5 (PDE5) in Brain.

Authors:  Jianrong Liu; Barbara Wenzel; Sladjana Dukic-Stefanovic; Rodrigo Teodoro; Friedrich-Alexander Ludwig; Winnie Deuther-Conrad; Susann Schröder; Jean-Michel Chezal; Emmanuel Moreau; Peter Brust; Aurélie Maisonial-Besset
Journal:  Pharmaceuticals (Basel)       Date:  2016-04-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.